AUTHOREA
Log in Sign Up Browse Preprints
Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Leukocyte chemotactic factor 2 related amyloidosis presented with severe jaundice and hepatic encephalopathy.
  • +4
  • Hussam Almasri,
  • Abdo Lutf,
  • Almurtada Razok,
  • Ahmed Badi,
  • Muneera Almohannadi,
  • Mahir Petkar,
  • Abdel-Naser Elzouki
Hussam Almasri
Hamad Medical Corporation

Corresponding Author:[email protected]

Author Profile
Abdo Lutf
Hamad Medical Corporation
Author Profile
Almurtada Razok
Hamad Medical Corporation
Author Profile
Ahmed Badi
Hamad Medical Corporation
Author Profile
Muneera Almohannadi
Hamad Medical Corporation
Author Profile
Mahir Petkar
Hamad Medical Corporation
Author Profile
Abdel-Naser Elzouki
Hamad Medical Corporation
Author Profile

Abstract

One of the most recently identified types is Leukocyte chemotactic factor 2 amyloidosis (LECT 2) which was found to be common in certain ethnic backgrounds. It is suggested that the diagnosis of this type is vital to prevent any therapy-related complications when it is erroneously diagnosed as AL amyloidosis.

Peer review status:ACCEPTED

12 Sep 2021Submitted to Clinical Case Reports
Show details
Hide details
15 Sep 2021Submission Checks Completed
15 Sep 2021Assigned to Editor
04 Oct 2021Reviewer(s) Assigned
21 Oct 2021Review(s) Completed, Editorial Evaluation Pending
01 Nov 2021Editorial Decision: Revise Minor
04 Nov 20211st Revision Received
20 Nov 2021Submission Checks Completed
20 Nov 2021Assigned to Editor
20 Nov 2021Review(s) Completed, Editorial Evaluation Pending
23 Nov 2021Editorial Decision: Accept